Laboratorios Farmaceuticos Rovi (STU:41L) Margin of Safety % (DCF Earnings Based): 33.34% (As of Jun. 25, 2026)


STU:41L Laboratorios Farmaceuticos Rovi SA STU:41L
99 GF Score
Price €59.25
GF Value €50.80
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Laboratorios Farmaceuticos Rovi Margin of Safety % (DCF Earnings Based)?

Laboratorios Farmaceuticos Rovi STU:41L +0.34% 99 Margin of Safety % (DCF Earnings Based) is 33.34% as of Jun. 25, 2026. GuruFocus rates STU:41L with a GF Score™ of 99/100 and a GF Value™ of €50.80 (Fairly Valued). The stock has 1 warning sign investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-25), Laboratorios Farmaceuticos Rovi's Predictability Rank is 4.5-Stars. Laboratorios Farmaceuticos Rovi's intrinsic value calculated from the Discounted Earnings model is €88.88 and current share price is €59.25. Consequently,

Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 33.34%.

STU:41L vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorios Farmaceuticos Rovi Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based) falls into.


STU:41L
99GF Score
Laboratorios Farmaceuticos Rovi SA STU:41L
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorios Farmaceuticos Rovi Margin of Safety % (DCF Earnings Based) Calculation

Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(88.88-59.25)/88.88
=33.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of 33.34% mean?
Laboratorios Farmaceuticos Rovi (STU:41L) has a Margin of Safety % (DCF Earnings Based) of 33.34% as of Jun. 25, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Laboratorios Farmaceuticos Rovi.
Is Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based) too high?
Laboratorios Farmaceuticos Rovi's current Margin of Safety % (DCF Earnings Based) is 33.34%. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based) compare to ZTS and UTHR?
Laboratorios Farmaceuticos Rovi's Margin of Safety % (DCF Earnings Based) of 33.34% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF Earnings Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Laboratorios Farmaceuticos Rovi. Laboratorios Farmaceuticos Rovi's current Margin of Safety % (DCF Earnings Based) is 33.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi (STU:41L) is currently considered Fairly Valued. The stock's GF Value™ is €50.80, compared to a current price of €59.25 — trading 16.6% above its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is 33.34%. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (STU:41L), the current Margin of Safety % (DCF Earnings Based) is 33.34% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorios Farmaceuticos Rovi (STU:41L) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued. The current stock price of €59.25 is trading 16.6% above its estimated GF Value™ of €50.80. GuruFocus considers Laboratorios Farmaceuticos Rovi to be Fairly Valued.

Key valuation signals for STU:41L:

  • Margin of Safety % (DCF Earnings Based): 33.34%
  • GF Value™: €50.80 vs. price of €59.25 (16.6% above fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the STU:41L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorios Farmaceuticos Rovi Business Description

Address Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
99GF Score

Get the complete analysis for STU:41L

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€59.25
Price
€50.80
GF Value